The aminocyclitols such as mannostatin, trehazolin, and allosamindin are well known to be powerful inhibitors of glycosidases.
The aminocyclitols such as mannostatin, trehazolin, and allosamindin are well known to be powerful inhibitors of glycosidases.
2) Recently, our group and Marco-Contelles/Chiaira's group have independently reported the investigations into the radical cyclization of oxime ethers as a useful method for preparing various types of five-membered aminocyclitols. [3] [4] [5] [6] [7] [8] In contrast, the synthesis of six-membered aminocyclitols has not been widely studied; thus, the synthesis of aminocyclohexitols based on the radical cyclization of oxime ethers derived from saccharides has been a subject of current interest due to their therapeutic applications. 9) Marco-Contelles/Chiaira's group reported the SmI 2 -mediated radical cyclization of oxime ether 1 giving the aminocyclohexitols 2 and 3 with low selectivity (Chart 1). 3, 4) In our recent studies on the radical reaction of oxime ether 4, we found that A 1, 3 -strain effect between the oxime ether group and a-substituents is important for stereocontrol of the benzyloxyamino group on product 5 (Chart 2). 10) In this paper, we report that the radical cyclization of oxime ether 6 proceeded with an excellent selectivity concerning the stereochemistry of the benzyloxyamino group on product 7 via favorable conformers minimizing A 1,3 -strain around the oxime ether group.
Results and Discussion
Oxime ether 6 was prepared as shown in Chart 3. According to the literature, 11) the commercially available 1,2,3,4,6-pentaacetyl-D-glucose 8 was treated with p-TolSH in the presence of BF 3 · OEt 2 to give 9. Deacetylation of 9 followed by selective protection of 4,6-hydroxyl groups using panisaldehyde dimethylacetal gave 10 in 96% yield. 12) Benzylation of 10 using benzyl bromide and NaH followed by treatment with NaBH 3 CN in the presence of trifluoroacetic acid (TFA) gave alcohol 12.
13) Treatment of 12 with N-iodosuccinimide (NIS) in the presence of AcOH gave the acetate 13 in 98% yield.
14) Subsequent deacetylation of 13 afforded the hemiacetal 14 in 96% yield, which was then treated with O-benzylhydroxyamine hydrochloride in pyridine to give oxime ether 15 in 91% yield, as an E/Z mixture in a 9 : 2 ratio. Treatment of 15 with 2,2-dimethoxypropane in the presence of p-TsOH gave the acetonide 16 in 94% yield. Deprotection of methoxyphenylmethyl (MPM) group of 16 by treatment with DDQ followed by mild oxidation of the resulting alcohol 17 with chromium(VI) oxide-pyridine afforded the aldehyde 6 as an E/Z mixture. In the recent studies on the radical reaction of oxime ether, we have observed no remarkable effect of the geometry of the starting oxime ether group on either the chemical yield or stereoselectivity by employing geometrically pure E-and Z-isomer. 15) Thus, oxime ether 6 was subjected to the following radical reactions, without the separation of E/Z-isomers.
We next examined the stannyl radical-promoted cyclization of oxime ether 6. Treatment of an E/Z mixture of 6 with tributyltin hydride in the presence of AIBN in boiling benzene gave a 3 : 1 mixture of two cyclized products trans-7 and cis-7 in 81% combined yield in favor of trans-7. As expected, the configuration of the benzyloxyamino group on product 7 was highly controlled in the radical cyclization of 6 as a result of A 1, 3 -strain effect around oxime ether group (Fig. 1) . The preferential formation of the trans-7 could be explained by less steric and electronic repulsions of the ketyl radical moiety and the oxime ether group. The rationale of the reaction pathway of this 6-exo-trig radical cyclization is that the stannyl radical initially reacted with the oxygen atom of the formyl group to form the ketyl radical which attacked intramolecularly the oxime ether group to give the cyclized products.
We were able to separate and purify isomers of trans-7 and cis-7 by the medium-pressure column chromatography. The configuration of the major product trans-7 was determined by X-ray analysis. The stereostructure of the minor product cis-7 was deduced from comparison of the 1 H-NMR spectrum with that of the major product trans-7 and from nuclear Overhanser effect (NOE) correlations.
The major product trans-7 was converted into the aminocyclohexitol derivative 20 (Chart 4). Reduction of the benzyloxyamino group of trans-7 with LiAlH 4 followed by N-acylation of the resulting crude amine with (Boc) 2 O afforded the N-Boc derivative 18 in 48% yield and the oxazolidone 19 in 42% yield. The N-Boc derivative 18 could be converted into the oxazolidone 19 in 61% yield by treatment with NaH in THF. The aminocyclohexitol derivative 20 was prepared by treatment of 19 with Dowex 50W-X8 in MeOH.
In conclusion, we have shown an A 1, 3 -strain effect on the stannyl radical mediated-cyclization of oxime ether derived from D-glucose for preparing the aminocyclohexitol derivative.
Experimental
General Melting points are uncorrected. 11) (50.0 g, 0.11 mol) in MeOH (600 ml) was added NaOMe (28% in MeOH, 2.57 ml) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 1 h, Dowex 50W-X8 was added to the reaction mixture. The reaction mixture was filtered and the filtrate was concentrated at reduced pressure to afford the alcohol. To a solution of the resulting alcohol in MeCN (350 ml) were added p-anisaldehyde dimethylacetal (37.5 ml, 0.22 mol) and p-TsOH (1.4 g, 7.26 mol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 20 h, Et 3 N (1.0 ml, 7.26 mmol) was added to the reaction mixture. After the reaction mixture was concentrated at reduced pressure, the resulting residue was diluted with AcOEt and then the organic phase was washed with 3% HCl, water, saturated NaHCO 3 , water, and saturated NaCl. The extract was dried over MgSO 4 
4-Methylphenyl (S)-4,6-O-[(4-Methoxyphenyl)methylene]-2,3-bis-O-(phenylmethyl)-1-thio-b b-D-glucopyranoside (11)
To a suspension of NaH (60% in mineral oil, 7.7 g, 0.19 mol) in DMF (50 ml) was added 10 (32.0 g, 76.5 mol) under a nitrogen atmosphere at 0°C. After being stirred at the same temperature for 30 min, benzyl bromide (20.2 ml, 0.17 mol) was added to the reaction mixture at 20°C. After being stirred at the same temperature for 20 h, the reaction mixture was diluted with Et 2 O and then the organic phase was washed with water, saturated NaHCO 3 , water, and saturated NaCl. The extract was dried over MgSO 4 
4-Methylphenyl (S )-6-O-[(4-Methoxyphenyl)methyl]-2,3-bis-O-(phenylmethyl)-1-thio-b b-D-glucopyranoside (12)
To a solution of 11 (10 g, 17.1 mmol), NaBH 3 CN (5.4 g, 85.5 mmol), and 4A MS (3.0 g) in DMF (30 ml) was added a solution of TFA (13.2 ml, 0.17 mol) in DMF (30 ml) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 20 h, acetone (5 ml) and Et 3 N (23.8 ml, 0.17 mmol) were added to the reaction mixture at 0°C. The reaction mixture was diluted with Et 2 O and then the organic phase was washed with 3% HCl, water, saturated NaHCO 3 , water, and saturated NaCl. The extract was dried over MgSO 4 and concentrated at reduced pressure. Purification by flash column chromatography (AcOEt/hexane 1 : 2) afforded 12 (9.4 under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 10 min, 12 (1.0 g, 1.70 mmol) was added to the reaction mixture at 20°C. After being stirred at the same temperature for 30 min, the reaction mixture was diluted with saturated sodium thiosulfate and CH 2 Cl 2 . The organic phase was washed with saturated NaHCO 3 , water, and saturated NaCl, dried over MgSO 4 , and concentrated at reduced pressure. Purification by flash column chromatography (AcOEt/hexane 1 : 2) afforded 13 (870 mg, 98%) as a colorless oil (a mixture of a/b-isomer). Methoxyphenyl)methyl]-2,3-bis-O-(phenylmethyl)-D-glucopyranose (14) To a solution of 13 (2.9 g, 5.57 mmol) in MeOH (30 ml) was added NaOMe (28% in MeOH, 0.12 ml) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 11 h, Dowex 50W-X8 was added to the reaction mixture. The reaction mixture was filtered and the filtrate was concentrated at reduced pressure. Purification by recrystallization (AcOEt) afforded 14 (2.6 g, 96%) as colorless crystals (a mixture of a/b-isomer). mp 111-114°C. 
6-O-[(4-

6-O-[(4-Methoxyphenyl)methyl]-2,3-bis-O-(phenylmethyl)-D-glucose O-(Phenylmethyl)oxime (15)
To a solution of 14 (24 mg, 0.05 mmol) in pyridine (0.3 ml) was added O-benzylhydroxylamine hydrochloride (8 mg, 0.05 mmol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 20 h, the reaction mixture was diluted with AcOEt and then the organic phase was washed with 3% HCl, water, saturated NaHCO 3 , water, and saturated NaCl. The extract was dried over MgSO 4 and concentrated at reduced pressure. Purification by preparative TLC (AcOEt/hexane 1 : 1) afforded 15 (26.6 mg, 91%) as a colorless oil (E : Zϭ9 : 2). 1 .20 mmol) in 2,2-dimethoxypropane (50 ml) was added pTsOH (65 mg, 0.34 mmol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 20 h, Et 3 N (0.05 ml, 0.36 mmol) was added to the reaction mixture, and then the reaction mixture was concentrated at reduced pressure. The residue was diluted with AcOEt and then the organic phase was washed with 3% HCl, water, saturated NaHCO 3 , water, and saturated NaCl. The extract was dried over MgSO 4 
H-NMR of E-isomer (CDCl
4,5-O-(1-Methylethylidene)-2,3-bis-O-(phenylmethyl)-D-glucose
O-(Phenylmethyl)oxime (17) To a solution of 16 (488 mg, 0.78 mmol) in CH 2 Cl 2 (7.9 ml) and H 2 O (0.5 ml) was added DDQ (267 mg, 1.17 mmol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 1 h, the reaction mixture was diluted with CH 2 Cl 2 and then the organic phase was washed with water and saturated NaCl. The extract was dried over MgSO 4 and concentrated at reduced pressure. Purification by flash column chromatography (AcOEt/hexane 1 : 2) afforded 17 (377 mg, 96%) as a colorless oil (E : Zϭ4 : 1). mmol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 15 min, a solution of 17 (982 mg, 1.94 mmol) in CH 2 Cl 2 (7.8 ml) was added to the reaction mixture. After the reaction mixture was stirred at the same temperature for 30 min, the solvent was evaporated at reduced pressure. After the resulting residue was diluted with Et 2 O and filtered through a pad of Celite, the filtrate was concentrated at reduced pressure. Purification by flash column chromatography (AcOEt/hexane 1 : 2) afforded 6 (937 mg, 96%) as a colorless oil (E : Zϭ5 : 1).
1 H-NMR of E-isomer (CDCl 3 ) d: 1.34 (3H, s), 1.55 (3H, s), 3.65 (1H, dd, Jϭ7, 2 
Radical Reaction of Oxime Ether 6
To a boiling solution of 6 (937 mg, 1.86 mmol) in benzene (14 ml) was added portionwise (5 ml/h) a solution of Bu 3 SnH (1.0 ml, 3.72 mmol) and AIBN (61 mg, 0.37 mmol) in benzene (4.0 ml) under a nitrogen atmosphere. The reaction mixture was heated at reflux for 1.5 h and then the solvent was evaporated at reduced pressure. The resulting residue was diluted with MeCN and the MeCN phase was washed with hexane and concentrated at reduced pressure. Purification by medium-pressure column chromatography (AcOEt/hexane 1 : 2) afforded cis-7 (207 mg, 22%) as a colorless oil and trans-7 (522 mg, 59%) as colorless crystals. Conversion of trans-7 to 18 and 19 To a solution of trans-7 (522 mg, 1.09 mmol) in THF (8.7 ml) was added LiAlH 4 (249 mg, 6.55 mmol) under a nitrogen atmosphere at 20°C. After the reaction mixture was heated at reflux for 1 h, the mixture was carefully diluted with Et 2 O and then excess of the reagent was decomposed by addition of water. The organic phase was washed with saturated NaCl, dried over MgSO 4 , and concentrated at reduced pressure to afford the amine. To a solution of the resulting amine in MeCN (20 ml) were added DMAP (122 mg, 1.09 mmol) and (Boc) 2 O (0.3 ml, 1.20 mmol) under a nitrogen atmosphere at 20°C. After being stirred at the same temperature for 20 h, the reaction mixture was concentrated at reduced pressure. Purification by medium-pressure column chromatography (AcOEt/hexane 1 : 1) afforded 18 (263 mg, 48%) as colorless crystals and 19 (193 mg, 42%) as colorless crystals. 
5-Deoxy-1,2-O-(1-methylethylidene)-5-[(phenylmethoxy)amino]-3,4-bis-O-(methylphenyl)-L-chiro-inositol (cis-7)
4-Deoxy-1,2-O-(1-methylethylidene)-4-[(phenylmethoxy)amino]-5,6-bis-O-(phenylmethyl)-D-myo-inositol (trans-7)
